Avoid common mistakes on your manuscript.
Erratum to: Pharm Res
DOI 10.1007/s11095-016-1978-1
In essence, the error in the article is related to:-
“The amount of Transferrin (Tf) that was conjugated to the liposomes was at concentrations of - ‘0.05, 0.1 and 0.2 mol%’ instead of the published ‘0.5, 1 and 2 mol%’.”
The authors would like to specify that the results and conclusions of the paper are not affected by this typing error.
In the table below, the details are specified for the changes.
Sr. No. | Location (Heading > Sub-heading > Line no. under the heading) | Change requested |
1 | Methods > Tf-Targeted Delivery Systems’ Association with Cells > Line 12 | 0.5, 1, 2 mol% to 0.05, 0.1, 0.2 mol% |
2 | Methods > Drug Delivery Systems Penetration of Spheroids > Line 3 | 0.5, 1, 2 mol% to 0.05, 0.1, 0.2 mol% |
3 | Results > Tf-Conjugated Delivery Systems’ Association with Cells > Line 11 | 0.5, 1, 2 mol% to 0.05, 0.1, 0.2 mol% |
4 | Results > Spheroid Cell Viability > Line 10 | 2 mol% to 0.2 mol% |
5 | Results > Spheroid Cell Viability > Line 13 | 1 mol% to 0.1 mol% |
6 | Discussion > Line 121 | 2 mol% to 0.2 mol% |
7 | Discussion > Line 123 | 2 mol% to 0.2 mol% |
8 | Discussion > Line 124 | 1 mol% to 0.1 mol% |
9 | Table 1 > Column 1 – Rows 7, 8, 9 | 0.5, 1, 2 mol% to 0.05, 0.1, 0.2 mol% |
10 | Figure 1 b > Bars 3, 4, 5 | 0.5, 1, 2 mol% to 0.05, 0.1, 0.2 mol% |
11 | Figure 4 a > Panel 2, 3, 4 | 0.5, 1, 2 mol% to 0.05, 0.1, 0.2 mol% |
12 | Figure 4 b > Legends | 0.5, 1, 2 mol% to 0.05, 0.1, 0.2 mol% |
13 | Figure 5 b > Bars 3, 4 | 1, 2 mol% to 0.1, 0.2 mol% |
14 | Figure 5 b > Description | 2 mol% to 0.2 mol% |
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at doi:10.1007/s11095-016-1978-1.
Rights and permissions
About this article
Cite this article
Pattni, B.S., Nagelli, S.G., Aryasomayajula, B. et al. Erratum to: Targeting of Micelles and Liposomes Loaded with the Pro-Apoptotic Drug, NCL-240, into NCI/ADR-RES Cells in a 3D Spheroid Model. Pharm Res 33, 2845–2846 (2016). https://doi.org/10.1007/s11095-016-2034-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-016-2034-x